This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Grace Gmbh, Københavns Universitet (University of Copenhagen), Union Therapeutics A/s. Active years: 2022-2024.
Company Filing History:
2 out of 15 
1 out of 1 
1 out of 22 Years Active: 2022-2024
Title: The Innovative Contributions of Thomas Rades
Introduction
Thomas Rades, based in Copenhagen, Denmark, is a prominent inventor who has made significant contributions to the field of pharmaceutical sciences. With a total of three patents to his name, his work primarily focuses on topical compositions and innovative particle technologies.
Latest Patents
One of Rades' notable patents is titled "Non-aqueous topical compositions comprising a halogenated salicylanilide." This invention relates to non-aqueous topical formulations that utilize halogenated salicylanilides for the treatment and prevention of skin conditions caused by Gram-positive bacteria. These skin conditions include acne, atopic dermatitis, and impetigo. The patent also discloses methods for preparing the gel composition, showcasing Rades' commitment to advancing topical therapeutic options.
Another significant patent is "Mechanochemical activated dry amorphisation by milling equilibrium between ap mesoporous silica." This patent focuses on the development of specific particles and outlines methods for their production and application. Rades' work in this area illustrates his innovative approach to improving pharmaceutical formulations through advanced material science techniques.
Career Highlights
Throughout his career, Thomas Rades has collaborated with esteemed organizations such as Grace GmbH and Union Therapeutics A/S. At these companies, Rades has been integral in research and development efforts, driving innovation in pharmaceutical solutions. His work is a perfect blend of research excellence and practical application, reflecting his dedication to improving healthcare outcomes.
Collaborations
Thomas Rades has worked alongside notable individuals in the industry, including Hans Hermann Hoefer and Thomas Pauly. These collaborations have enriched his research endeavors and contributed to the successful development of his patents. Working with other experts has allowed Rades to expand his knowledge and refine his inventions.
Conclusion
Thomas Rades continues to make impactful strides in pharmaceutical innovation. His patents reflect his expertise and forward-thinking approach to addressing critical healthcare challenges. With his contributions, he is not only enhancing the treatment of skin infections but is also paving the way for the future of topical therapeutic options.